# Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects

> **NCT01662440** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 661 (actual)

## Conditions studied

- Rabies
- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Rabies
- **BIOLOGICAL:** Japanese Encephalitis
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01662440
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-12
- **Final completion:** 2013-10
- **Target enrollment:** 661 (ACTUAL)
- **Last updated:** 2014-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01662440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01662440, "Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01662440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*